165 related articles for article (PubMed ID: 2749584)
1. Significance of plasma adenosine in the antiplatelet activity of forskolin: potentiation by dipyridamole and dilazep.
Agarwal KC; Zielinski BA; Maitra RS
Thromb Haemost; 1989 Feb; 61(1):106-10. PubMed ID: 2749584
[TBL] [Abstract][Full Text] [Related]
2. Role of adenosine uptake and metabolism by blood cells in the antiplatelet actions of dipyridamole, dilazep and nitrobenzylthioinosine.
Dawicki DD; Agarwal KC; Parks RE
Biochem Pharmacol; 1985 Nov; 34(22):3965-72. PubMed ID: 4062970
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of the antiplatelet action of adenosine in whole blood by dipyridamole or dilazep and the cAMP phosphodiesterase inhibitor, RA 233.
Dawicki DD; Agarwal KC; Parks RE
Thromb Res; 1986 Jul; 43(2):161-75. PubMed ID: 3016942
[TBL] [Abstract][Full Text] [Related]
4. Role of plasma adenosine in the antiplatelet action of HL 725, a potent inhibitor of cAMP phosphodiesterase: species differences.
Agarwal KC; Buckley RS; Parks RE
Thromb Res; 1987 Jul; 47(2):191-200. PubMed ID: 2821650
[TBL] [Abstract][Full Text] [Related]
5. Adenosine metabolism in human whole blood. Effects of nucleoside transport inhibitors and phosphate concentration.
Dawicki DD; Agarwal KC; Parks RE
Biochem Pharmacol; 1988 Feb; 37(4):621-6. PubMed ID: 3342099
[TBL] [Abstract][Full Text] [Related]
6. Is adenosine involved in inhibition of forskolin-stimulated cyclic AMP accumulation by caffeine in rat brain?
Mante S; Minneman KP
Mol Pharmacol; 1990 Nov; 38(5):652-9. PubMed ID: 2172772
[TBL] [Abstract][Full Text] [Related]
7. [Inhibition of induced thrombocyte aggregation in the presence of endothelial cells by dipyridamole].
Kirchmaier CM; Altorjay J; Bellinger O; Breddin HK
Vasa Suppl; 1991; 32():318-21. PubMed ID: 1771524
[TBL] [Abstract][Full Text] [Related]
8. Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood).
Violi F; Praticò D; Iuliano L; Balsano F
J Lipid Mediat; 1991; 4(1):61-7. PubMed ID: 1909906
[TBL] [Abstract][Full Text] [Related]
9. Adenosine-mediated killing of cultured epithelial cancer cells.
Barry CP; Lind SE
Cancer Res; 2000 Apr; 60(7):1887-94. PubMed ID: 10766176
[TBL] [Abstract][Full Text] [Related]
10. Adenosine-mediated inhibition of platelet aggregation by acadesine. A novel antithrombotic mechanism in vitro and in vivo.
Bullough DA; Zhang C; Montag A; Mullane KM; Young MA
J Clin Invest; 1994 Oct; 94(4):1524-32. PubMed ID: 7929829
[TBL] [Abstract][Full Text] [Related]
11. Dipyridamole inhibits platelet aggregation in whole blood.
Gresele P; Zoja C; Deckmyn H; Arnout J; Vermylen J; Verstraete M
Thromb Haemost; 1983 Dec; 50(4):852-6. PubMed ID: 6665766
[TBL] [Abstract][Full Text] [Related]
12. Dipyridamole potentiates platelet inhibition by nitric oxide.
Bult H; Fret HR; Jordaens FH; Herman AG
Thromb Haemost; 1991 Sep; 66(3):343-9. PubMed ID: 1746006
[TBL] [Abstract][Full Text] [Related]
13. Calcium entry blocking activity of dilazep and other adenosine potentiating compounds in guinea-pig atria.
Nakagawa Y; Gudenzi M; Mustafa SJ
Eur J Pharmacol; 1986 Mar; 122(1):51-8. PubMed ID: 3956577
[TBL] [Abstract][Full Text] [Related]
14. A comparative study on the effect of dilazep and dipyridamole on some platelet functions.
Valori VM; Leone G; Traisci G; Bizzi B
Arzneimittelforschung; 1982; 32(4):403-5. PubMed ID: 7201810
[TBL] [Abstract][Full Text] [Related]
15. Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazep.
Parks RE; Dawicki DD; Agarwal KC; Chen SF; Stoeckler JD
Ann N Y Acad Sci; 1985; 451():188-203. PubMed ID: 3878117
[No Abstract] [Full Text] [Related]
16. Dilazep and dipyridamole inhibit tissue factor expression on monocytes induced by IgG from patients with antiphospholipid syndrome.
Zhou H
Acta Pharmacol Sin; 2004 Oct; 25(10):1366-71. PubMed ID: 15456541
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human and rat platelet aggregation by extracts of Mo-er (Auricularia auricula).
Agarwal KC; Russo FX; Parks RE
Thromb Haemost; 1982 Oct; 48(2):162-5. PubMed ID: 6983740
[TBL] [Abstract][Full Text] [Related]
18. Human platelet aggregation tests in vitro. Effects of dilazep.
Ponari O; Manotti C
Arzneimittelforschung; 1981; 31(1):97-101. PubMed ID: 7194099
[TBL] [Abstract][Full Text] [Related]
19. The antilipolytic effect of endogenous and exogenous adenosine in canine adipose tissue in situ.
Sollevi A; Fredholm BB
Acta Physiol Scand; 1981 Sep; 113(1):53-60. PubMed ID: 7315438
[TBL] [Abstract][Full Text] [Related]
20. Species differences in sensitivity of nucleoside transport in erythrocytes and cultured cells to inhibition by nitrobenzylthioinosine, dipyridamole, dilazep and lidoflazine.
Plagemann PG; Woffendin C
Biochim Biophys Acta; 1988 Apr; 969(1):1-8. PubMed ID: 3349106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
